Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prudence A Russell

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Clinical Lung Cancer|September 13, 2018
Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging SystemZoe Wainer, Gavin M Wright, Karla Gough, et al.
Cancer Research|January 9, 2016
IL6 Trans-signaling Promotes KRAS-Driven Lung CarcinogenesisGavin D Brooks, Louise McLeod, Sultan Alhayyani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
The clinical relevance of pathologic subtypes in metastatic lung adenocarcinomaTimothy D Clay, Hongdo Do, Vijaya Sundararajan, et al.
Pathology|August 17, 2017
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patientsPrudence A Russell, Toni-Maree Rogers, Benjamin Solomon, et al.
ANZ Journal of Surgery|September 15, 2016
Impact of sex on prognostic host factors in surgical patients with lung cancerZoe Wainer, Gavin M Wright, Karla Gough, et al.
Pathology|May 24, 2024
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literatureAniza Hassan, Sarita Prabhakaran, Emily Pulford, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patientsPrudence A Russell, Stephen A Barnett, Marzena Walkiewicz, et al.
Pathology|December 5, 2013
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinomaPrudence A Russell, Yong Yu, Hongdo Do, et al.
Medical Oncology (Northwood, London, England)|September 8, 2017
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinomaTimothy D Clay, Prudence A Russell, Hongdo Do, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Clinical Lung Cancer|September 13, 2018
Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging SystemZoe Wainer, Gavin M Wright, Karla Gough, et al.
Cancer Research|January 9, 2016
IL6 Trans-signaling Promotes KRAS-Driven Lung CarcinogenesisGavin D Brooks, Louise McLeod, Sultan Alhayyani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
The clinical relevance of pathologic subtypes in metastatic lung adenocarcinomaTimothy D Clay, Hongdo Do, Vijaya Sundararajan, et al.
Pathology|August 17, 2017
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patientsPrudence A Russell, Toni-Maree Rogers, Benjamin Solomon, et al.
ANZ Journal of Surgery|September 15, 2016
Impact of sex on prognostic host factors in surgical patients with lung cancerZoe Wainer, Gavin M Wright, Karla Gough, et al.
Pathology|May 24, 2024
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literatureAniza Hassan, Sarita Prabhakaran, Emily Pulford, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patientsPrudence A Russell, Stephen A Barnett, Marzena Walkiewicz, et al.
Pathology|December 5, 2013
EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinomaPrudence A Russell, Yong Yu, Hongdo Do, et al.
Medical Oncology (Northwood, London, England)|September 8, 2017
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinomaTimothy D Clay, Prudence A Russell, Hongdo Do, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Pageof 6